Instituto do Câncer do Ceará

What Instituto do Câncer do Ceará does

Rede ICC Saúde (Instituto do Câncer do Ceará) is a Brazilian filantropic (non-profit) healthcare network founded in 1944 in Fortaleza, Ceará, that operates an integrated portfolio spanning oncology, cardiology, pediatrics, mental health, primary care, health insurance, pharmacy, education, and innovation. Its core asset is Hospital Haroldo Juaçaba, a 27-year-old oncology reference hospital that records 380,000+ annual patient visits and houses the largest radiotherapy park in North-Northeast Brazil, complemented by Hospital Santa Cecília (high-complexity and cardiology in Volta Redonda, RJ, acquired 2020) and Hospital São Raimundo (cardiology and pediatrics in Fortaleza, acquired 2023). The network invests in advanced oncology technology including a Halcyon radiotherapy platform (acquired 2026 via the Ministry of Health's Radiotherapy Expansion Program), robotic surgery, SBRT/IMRT-VMAT, genomic sequencing through ICC Genômica, and a planned PET-CT unit funded via PRONON.

The commercial stack combines direct-to-consumer hospital services accessed through SUS (the Brazilian public healthcare system), 25+ private health insurance operators at Hospital Haroldo Juaçaba and 20+ at Hospital São Raimundo, and a proprietary health insurance operator (LIVSAÚDE) active in Ceará and Rio de Janeiro. Adjacent businesses include Amparo Cuidado (a digital primary-care platform with 24/7 telemedicine and nurse navigation for chronic-disease patients), Amparo Farmácia (integrated pharmacy), Thera Saúde Mental (mental-health outpatient services), ICC Genômica (genetic testing and targeted-therapy selection), ICC Biolabs (health innovation hub and startup accelerator, the largest in North-Northeast Brazil), and ICC Ensino e Pesquisa (academic programs including the only Master's in Oncology in North-Northeast Brazil). The network operates as a non-profit philanthropic entity under the Juaçaba/Alcântara founding families, with Dr. Sérgio Juaçaba as President (since July 2024), Caio Juaçaba as CEO, and Pedro Meneleu as CSO. Revenue is generated through hospital service fees, SUS contracts, private insurance reimbursement, health insurance premiums, tuition, and innovation partnerships, but specific revenue figures are not publicly disclosed.

Name

Instituto do Câncer do Ceará

Legal name

Grupo ICC

Website

https://icc.org.br

Company type

Private

Founded year

1944

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Rede ICC Saúde is a Brazilian non-profit healthcare network operating oncology, cardiology, and specialty hospitals in Ceará and Rio de Janeiro, alongside health insurance, pharmacy, genomics, digital primary care, and an innovation hub serving SUS and private patients across North-Northeast Brazil.

Ownership category

akta.pro rank

Product category

Oncology Hospital and Integrated Healthcare Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), General Medical and Surgical Hospitals (6221), Medical and Diagnostic Laboratories (6215), Diagnostic Imaging Centers (621512), Offices of Physicians, Mental Health Specialists (621112)

SIC

Services-Hospitals (8060), Services-Medical Laboratories (8071), Hospital & Medical Service Plans (6324)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industries

Academic Medical Centers (AMCs) & Teaching Hospitals (HLAFAAAA), Oncology Telemedicine Platforms (HLALAGAH), Academic Medical Centers & Teaching Hospitals (University-Affiliated) (EDAHAGAA), Clinical Trial Monitoring Support (On-site/Remote) (HLAGACAG)

Keywords

• Oncology hospital services
• Cancer treatment center
• Health insurance plans
• Medical residency education
• Health innovation hub

Headquarters

HQ city

Fortaleza

HQ country

Brazil

HQ region

Latin America

Offices5 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Hospital and Clinical Services: Revenue from oncology, cardiology, and specialty healthcare services delivered at three hospitals (Haroldo Juaçaba, Santa Cecília, São Raimundo) through SUS contracts, private insurance reimbursement, and direct patient payment
2. LIVSAÚDE Health Insurance: Operating as a health insurance operator (operadora de planos de saúde) serving Ceará and Rio de Janeiro with personalized and integrated care plans
3. ICC Biolabs Innovation Services: Innovation hub providing acceleration and incubation services for health and biotech startups, generating revenue through innovation partnerships and ecosystem development
4. Education and Research Programs: Revenue from academic programs including master's degrees in oncology, medical residencies, and continuing education courses offered through ICC Ensino e Pesquisa
5. PRONON Social Project Donations: Funding through the National Program for Oncology Support (PRONON) for social projects including PET-CT implementation, enabled by partnerships with companies and institutions

Go-to-market motion2 records

Distribution channels8 records

Marketing channels9 records

Core offering

Rede ICC Saúde operates an integrated non-profit healthcare network anchored by Hospital Haroldo Juaçaba, an oncology reference in Fortaleza providing comprehensive cancer care (surgery, chemotherapy, radiotherapy, robotic surgery, and genomic testing). The network also operates two additional hospitals (Santa Cecília and São Raimundo), a health insurance operator (LIVSAÚDE), genomic services (ICC Genômica), a primary care and telemedicine platform (Amparo Cuidado), pharmacy services (Amparo Farmácia), mental health (Thera Saúde Mental), education and research (ICC Ensino e Pesquisa), a health innovation hub (ICC Biolabs), and social support housing (Casa Vida).

Product overview

Rede ICC Saúde is a comprehensive health ecosystem composed of multiple complementary businesses forming one of Brazil's largest healthcare complexes. The portfolio centers on Hospital Haroldo Juaçaba, a pioneering oncology reference in northern-northeastern Brazil, alongside Hospital Santa Cecília (cardiology/high complexity in Rio de Janeiro) and Hospital São Raimundo (cardiology in Fortaleza). Supporting the hospital network are health insurance (LIVSAÚDE), genomic services (ICC Genômica), innovation hub (ICC Biolabs), primary care (Amparo Cuidado), pharmacy (Amparo Farmácia), mental health (Thera Saúde Mental), education and research (ICC Ensino e Pesquisa), and social support (Casa Vida). The network integrates medical assistance, teaching, research, and technology to deliver accessible, high-quality healthcare.

Differentiator

Problem solved

Functional benefit

Brands

• Amparo Cuidado: Primary care solution for patients with chronic conditions, offering telemedicine 24/7, navigator nurses, and digital health monitoring.
• Amparo Farmácia
• Hospital Haroldo Juaçaba
• Hospital Santa Cecília
• Hospital São Raimundo
• Thera Saúde Mental
• LIVSAÚDE
• ICC Ensino e Pesquisa
• ICC Biolabs
• Casa Vida
• ICC Genômica

Products and services

• Hospital Haroldo Juaçaba Oncology reference hospital in Fortaleza-CE with 27+ years of experience, 380,000+ annual patient visits, and 30+ clinical and general specialties, serving SUS, 25+ private health insurance plans, and private patients.
• Hospital Santa Cecília High-complexity hospital in Volta Redonda-RJ with a modern diagnostic center, general ICU, cardio-intensive unit, surgical center, and 40+ medical specialties for SUS and private patients.
• Hospital São Raimundo Hospital in Aldeota, Fortaleza specializing in cardiology and pediatrics, accepting 20+ convênios and private patients, integrated into the ICC Health Network.
• LIVSAÚDE Health Insurance Health insurance operator serving Ceará and Rio de Janeiro, offering personalized and integrated care plans with multidisciplinary teams and access to ICC hospitals, clinics, and laboratories.
• ICC Genômica Genomic service providing predictive analysis, hereditary cancer genetic testing (including BRCA), tumor mutation analysis for targeted therapies, and personalized prevention and treatment plans for oncology patients.
• ICC Biolabs Health innovation hub accelerating and incubating health and biotech startups through open innovation programs, the largest specialized health innovation hub in North-Northeast Brazil.
• Amparo Cuidado Digital primary care solution for people living with chronic conditions offering 24/7 telemedicine, navigator nurses, technology-assisted monitoring, daily symptom and mood tracking via mobile app, and predictive analytics for proactive care.
• Amparo Farmácia Integrated pharmaceutical assistance service extending coordinated care through convenience, access, and solutions that strengthen treatment continuity for ICC patients.
• Thera Saúde Mental Mental health care service offering integrated, humanized care with multidisciplinary teams, combining outpatient care, therapies, and specialized support across the patient journey.
• ICC Ensino e Pesquisa Education and research institution offering undergraduate programs, scientific initiation, postgraduate studies, the only Master's in Oncology in North-Northeast Brazil, medical residencies, multi-professional residencies, fellowship in urological robotic surgery, and clinical research programs.
• Casa Vida Accommodation and emotional support house for SUS oncology patients undergoing treatment at Hospital Haroldo Juaçaba, offering lodging, meals, communal spaces, and integral assistance.

Quantifiable outcome

• 380,000+ annual patient visits at Hospital Haroldo Juaçaba
• +4 more outcomes

Named customers3 records

Segments7 records

Ideal customer profiles6 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature6 records

Partnerships

Three partnerships are on record, tiered core.

• Brazilian Ministry of HealthcoreStrategic or Co-development Partner · 1 January 2026Partnership through the Programa Nacional de Apoio à Atenção Oncológica (PRONON) for funding social projects including PET-CT implementation at ICC. The Ministry of Health's Radiotherapy Expansion Program also enabled acquisition of the Halcyon Platform for advanced cancer treatment.
• Universidade Federal do Ceará (UFC)coreStrategic or Co-development PartnerHistorical partnership since 1948 when ICC's outpatient clinic moved alongside the Faculty of Medicine to the Porangabussu campus. ICC operates adjacent to the medical school complex and provides clinical training grounds for medical students.
• ICC Biolabs Startup EcosystemcoreStrategic or Co-development PartnerICC Biolabs functions as an ecosystem connecting startups, investors, and institutions for healthcare innovation, implementing innovation culture within Rede ICC Saúde through acceleration and incubation programs.

Scale indicators10 records

Recent moves11 records

Expansion highlights7 records

Direct peers

• Hospital de Amor (Barretos): Brazil's other leading philanthropic oncology specialty hospital network, with multi-state facilities offering comprehensive cancer care, research, and prevention programs — directly comparable to ICC's Haroldo Juaçaba model.
• A.C. Camargo Cancer Center: Specialty oncology hospital in São Paulo combining diagnosis, treatment, research, and graduate education — closely mirrors ICC's integrated oncology, research, and teaching mission.
• GRAACC: Specialty pediatric oncology hospital in São Paulo combining clinical care, research, and teaching — comparable in philanthropic oncology specialization.
• Grupo Oncoclínicas: Largest Brazilian oncology clinic network operating across multiple states with genomics, radiotherapy, and clinical research — directly comparable multi-state oncology platform.

Broad incumbents

• Hospital Israelita Albert Einstein: Major Brazilian tertiary hospital system with oncology, genomic medicine, teaching, and innovation arms — a benchmark incumbent across ICC's full service stack.
• Rede D'Or São Luiz: Largest private hospital network in Brazil with oncology, diagnostic imaging, and insurance-adjacent operations — comparable in scale and vertical breadth.
• Hospital Sírio-Libanês: High-complexity tertiary hospital in São Paulo with strong oncology, genomics, and teaching programs — a broader incumbent in the same specialty care space.

Regional players

• Hospital Pequeno Príncipe: Specialty pediatric hospital in Curitiba combining complex care, research, and education — comparable in philanthropic teaching-hospital model with strong specialty positioning.
• Hospital Mãe de Deus: High-complexity hospital group in southern Brazil (Rio Grande do Sul) with multi-specialty care and oncology programs — comparable in tertiary positioning but distinct geography.

Emerging players

• Hapvida NotreDame Intermédica: Vertically integrated health plan + hospital operator in Brazil; comparable to ICC's LIVSAÚDE + hospital strategy, though operating at national scale with a generalist focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCYrZrdAGs73SlXTlJ97bDRg
• Facebookfacebook.com/RedeICC
• LinkedInlinkedin.com/company/redeicc
• Instagraminstagram.com/redeicc

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Instituto do Câncer do Ceará